A detailed history of Morgan Stanley transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Morgan Stanley holds 130,139 shares of THRD stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130,139
Previous 192,451 32.38%
Holding current value
$1.69 Million
Previous $2.11 Million 41.83%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$8.6 - $11.24 $535,883 - $700,386
-62,312 Reduced 32.38%
130,139 $1.23 Million
Q4 2023

Feb 13, 2024

BUY
$5.97 - $11.47 $512,978 - $985,571
85,926 Added 80.66%
192,451 $2.11 Million
Q3 2023

Nov 15, 2023

SELL
$4.92 - $7.09 $130,837 - $188,544
-26,593 Reduced 19.98%
106,525 $680,000
Q2 2023

Aug 14, 2023

BUY
$4.18 - $5.33 $191,974 - $244,790
45,927 Added 52.67%
133,118 $640,000
Q1 2023

May 15, 2023

BUY
$3.95 - $4.49 $160,591 - $182,545
40,656 Added 87.37%
87,191 $359,000
Q4 2022

Feb 14, 2023

BUY
$4.0 - $22.0 $157,500 - $866,250
39,375 Added 549.93%
46,535 $200,000
Q3 2022

Nov 14, 2022

BUY
N/A
7,160 New
7,160 $136,000

Others Institutions Holding THRD

About Third Harmonic Bio, Inc.


  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $524M
More about THRD
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.